NOS2 and invasive ductal breast carcinoma: Patient survival analysis demonstrated a correlation between increased NOS2 expression and worse survival at 5 years in patients with invasive ductal breast carcinoma (n = 79) (fold change 1.275, P = 0.037) (Figure 1B).